buy momentum management meet highlight
take ceo jon ayer cfo brian corp strategy/ir
kerri bennett highlight sustain leadership posit
innov test capabl expand global footprint robust
commerci strategi note strong fundament even develop
market us under-penetrated re-affirmed guid
org revenue recur bp op margin expans
maintain ep ep move
stronger revenu profit tp move
higher view greater convict lt growth prospect
global dog nostic frontier commit increasingli
sophist commerci effort support dd organ revenu growth
lt well ahead industri global expans key driver
estimate target area identifi proprietari geographic-specif
algorithm disclos invest top-rank brakk studi us sale
forc rep rep reflect previou guidanc
term sale cycl
pet-tech advantag next address evolv
competit landscap emphas potenti benefit disrupt
zoeti pend acquisit abaxi abax indic yesterday
comprehens portfolio along cohes platform solut
offer sticki busi model competitor lack broadli
zoeti also bring anoth global voic promot diagnost ou
market still fledgl stage adopt strong cash flow
fund share repurchas occasion tuck-in catalyst soc
rickettsiolog rapid assay competit landscap
boston ndr earn updat target
advantag
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
global leader diagnost point-of-car equip
refer laboratori servic companion anim also
provid system diagnost livestock water qualiti
price may rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
gain refer laboratori point-of-car acceler global
expans greater contribut innov new product
launch technolog advanc greater expect
growth broader anim health industri fundament
stronger expect macroeconom fx headwind
increasingli global footprint less adoption/tract futur product
launch deterior veterinari health fundament
takeaway manag
manag continu view industri fundament robust overal global
diagnost market growth trend consist exceed evidenc
organ growth above-market organ growth attribut
continu innov across diagnost softwar platform geograph
expans matur increasingli sophist commerci effort
emphas even develop market us remain highli
under-penetrated term diagnost util exampl million
dog per appa us estim million undergo annual
heartworm exam importantli clinic visit across advanc
adopt prevent care protocol evolv client base also support
growth longer term mega-trend industri emphas opportun greater
adopt prevent diagnost canin geriatr dog optic
healthi veterinari visit would issu detect via diagnost
exam highlight valu greater veterinari educ even substanti
american societi rickettsiolog june potenti new studi compar
investor day august potenti updat target
figur driver revenu
note us dx base growth includ pet visit growth dx revenu per pet visit net custom addit dx base growth includ
base market growth catalyst expans benefit
remain lead innov dog nostic repres industri
manag emphas rich pipelin beyond even disclos lt
target offer compel potenti upsid futur effort also continu
focu integr softwar system note spent million
softwar develop past decad distinguish
competit continu lack compar cohes ecosystem term new
product maintain expect fecal snap launch begin
tweak collection/workflow aspect admittedli better time industri confer
manag concern potenti fast imit note hold strong ip
patent key product also continu upgrad exist product line
provid manag confid continu realiz annual price gain
forese futur program detail also make
compani industry-lead product access veterinarian
enhanc idxx brand veterinari standard care
vs snap guidanc risk-adjust rang potenti competit
impact abax recent rapid assay launch compet flagship
snap test howev manag note veterinarian tick-born area
highlight perform issu expect potenti comparison studi
american societi rickettsiolog confer june addit
believ acquisit abax could also lead distributor deemphas
among disrupt factor therefor repres potenti sourc
upsid idxx estim view
intern market expand meaning improv standard care
grow pet popul intern market intern recur
revenu grow compound-annual-growth-rate dog nostic adopt
woefulli under-penetrated potenti meaning uplift util
sizeabl upgrad vettest instal base greenfield placement opportun
along evolv standard care note profit across core instrument
consum busi abroad vari similar compar domest
busi intern refer laboratori busi inher less profit
better leverag infrastructur time
china focu manag character chines market area focu well
competit note competitor japan-bas fuji less advanc local
player china strong companion anim growth china driven potenti part
countri singl child polici histor expect continu
aggress place instrument across region importantli manag note
hematolog market china especi strong posit well
sophisticated/comprehens platform includ procyt dx analyz industri
leader also highlight recent proprietari us veterinari survey see figur
address evolv competit landscap zoeti abaxi
manag broadli deemphas competit threat acquisit abax
see note view signific valu larg pharmaceut compani
promot import diagnost global presenc combin
industry-lead suit product could work advantag notabl
manag downplay abil bundl pharmaceut product diagnost
highlight vast differ two purchas decis veterinarian
howev view could opportun leverag sizeabl
global sale footprint diagnost pipelin time also focu product
anim intern market view room one player
highli under-penetrated area deemphas direct nt competit threat
leadership posit fact like disrupt zts/abax combin
interestingli depict abaxi yesterday could repres meaning
opportun
stress potenti promot livestock diagnost anoth posit
histor accord larg anim health pharmaceut
compani deemphas signific diagnost favor vaccin anti-
infect addit manag believ abax instrument well-suit
success detect livestock infecti diseas requir advanc
technolog still categori broadli under-penetrated put perspect
livestock repres busi vast major ou leader
categori global
note manag also deemphas likelihood larg pharma anim
health compani merck anim health eli lilli elanco busi
enter diagnost space note intens competit necessari know-
critic sustain long term success regard acquir diagnost
compani access relev anim health data manag note market
anim health diagnost data pharmaceut compani much cheaper rate
premium requir purchas dognost player interestingli said work
boehring ingelheim legaci merial anim health busi
impress compani sophist data focu
week disclos add field base sale repres
bring total us sale forc rep follow success previou two sale
forc expans high roi importantli increment invest associ
ad sale forc alreadi reflect guidanc
sale effort also includ top veterinarian perform peer-to-p educ
clinic veterinarian order teach valu prevent anim health medicin
diagnost test importantli manag emphas low turnov rate high
engag level among sale forc continu poach industri
constitu includ larg pharma view zoeti effort meaning
sale forc guid idxx sophist econom valu index sale forc
incent structur launch us year ago expand intern
align sale rep incent econom valu provid greater
compens instrument placement gener stronger recur revenu
stream captur gross margin instrument associ consum
seven year period enabl sale personnel higher-octan placement
facilit strength recur revenu stream cite intern
implement key driver robust intern growth also
note manag util internally-develop proprietari market-s algorithm
assess longer term recur revenu opportun geographic-specif market
intern manag detail
program creativ solut attract price-consci veterinarian launch us
idexx provid custom instrument return six-year subscription-
style contract requir veterinarian purchas relat consum
life contract importantli program boost sedivu catalyst
placement promot adopt new product acceler posit word
mouth critic benefit veterinarian histor known slow adopt note
expect launch intern
strong cash flow gener net incom support continu
share repurchas contribut percentag point five-year ep
growth target net debt current stand ebitda comfort
increas leverag past histori hold opportunist acquisit
infrequ small potenti focus technolog softwar tuck-in either
complement veterinari suit add practic manag capabl data
step capital-expenditure year million associ two on-going project
compani expand main headquart seat though local tax incent
off-set good portion cost burden reloc core refer lab
germani nearbi locat expand capac remind idxx leipzig
germani facil central hub european refer laboratori offer
opportun vet first choic manag believ henri schein/vet
first choic transact see note repres posit promot
develop companion anim health market pet owner complianc
note despit share tie david shaw founder vet first choic
chairman common maine-bas resid compani
meaning relationship sophist veterinari busi also
enhanc idxx softwar busi includ cornerston pim applic
datapoint middlewar busi
competit account
competit account
charl martineau univers toronto figur cs survey view launch
sdma meaning compel offer
figur cs survey would prefer
sdma test offer in-hous analyz
neither see
valu sdma
indiffer
sdma
offer
laboratori in-
sdma
offer in-
sdma
refer
number respond
compani mention price
